✅ Product Benefits

1. Broad-spectrum efficacy — Combines cefuroxime (a bactericidal second‑generation cephalosporin) with clavulanic acid (a β‑lactamase inhibitor) to tackle both Gram‑positive and Gram‑negative, including β‑lactamase–producing strains 

2. Multiple indication coverage — Effective in treating pharyngitis, tonsillitis, sinusitis, otitis media, bronchitis, pneumonia, skin and soft tissue infections, urinary tract infections, gonorrhoea, early Lyme disease, MDR typhoid fever, and postoperative prophylaxis .

3. Flexible dosing — Standard adult regimen is 250–500 mg twice daily for 5–14 days depending on infection; pediatric dosing adjusted based on weight (20–30 mg/kg/day in divided doses) 

4. Convenient administration — May be taken with or without food, aiding adherence; fixed twice‑daily schedule enhances compliance 

5. Well-established safety profile — Generally well-tolerated; common adverse effects include nausea, vomiting, diarrhea, abdominal discomfort; rare but serious reactions may include anaphylaxis, renal dysfunction, pseudomembranous colitis, rash, and serum sickness‑like reactions